论文部分内容阅读
目的:泮托拉唑联合康复新液治疗十二指肠球部溃疡的效果观察。方法:在我院2015年8月-2016年3月接受诊治的十二指肠球部溃疡患者中筛选出66例,根据不同的治疗方法,将66例十二指肠球部溃疡患者分为每组各33例的对照组和观察组。给予对照组患者泮托拉唑治疗,给予观察组患者泮托拉唑联合康复新液治疗,观察和比较两组患者的溃疡愈合效果、幽门螺杆菌根除情况、症状缓解情况、不良反应发生情况。结果:观察组的溃疡愈合率是97.0%、幽门螺杆菌根除率是97.0%,对照组的溃疡愈合率是72.7%、幽门螺杆菌根除率是70.0%,差异显著,P<0.05,有统计学意义。观察组的不良反应发生率是15.1%,对照组的不良反应发生率是9.0%,P>0.05,没有显著差异,无统计学意义。结论:泮托拉唑联合康复新液治疗十二指肠球部溃疡,可以显著治愈溃疡,不良反应发生少,值得临床推广。
Objective: To observe the curative effect of pantoprazole and kangfuxinye on duodenal ulcer. Methods: 66 cases of duodenal ulcer patients treated in our hospital from August 2015 to March 2016 were selected. According to different treatment methods, 66 cases of duodenal ulcer patients were divided into Each group of 33 cases of control group and observation group. The patients in the control group were treated with pantoprazole, and the patients in the observation group were treated with pantoprazole combined with rehabilitation new liquid. The ulcer healing, helicobacter pylori eradication, symptom relief and adverse reactions in the two groups were observed and compared. Results: The healing rate of ulcer in the observation group was 97.0%, the rate of H. pylori eradication was 97.0%, the healing rate of ulcer in the control group was 72.7% and the rate of H. pylori eradication was 70.0% (P <0.05) significance. The incidence of adverse reactions in the observation group was 15.1%, the incidence of adverse reactions in the control group was 9.0%, P> 0.05, no significant difference, no statistically significant. Conclusion: The combination of pantoprazole and kangfuxin liquid in the treatment of duodenal ulcer can cure ulcers remarkably with fewer adverse reactions and is worthy of clinical promotion.